Dr. Marshall Summar, MD

  • Washington, DC
  • Clinical genetics (m.d.) physician
NPI1336231745
Publications
150
Clinical trials
6
Industry payments
$21,478
Affiliated sites
1
Medical group
1
Practice address
5550 Friendship Blvd Ste 580 Suite 580, Chevy Chase, MD 20815
Practice phone
Call (240) 338-1217
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Children's Hospital - Chevy Chase

Pediatric practice · Chevy Chase, Maryland

Find Dr. Summar's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Marshall Summar is a clinical genetics (m.d.) physician in Washington, District of Columbia

Dr. Summar practices at Children's Hospital - Chevy Chase in Chevy Chase, Maryland.

Dr. Summar's NPI, 1336231745, was assigned on September 30, 2006. Dr. Summar graduated from University of Tennessee Health Science Center College of Medicine - Memphis in 1985. Dr. Summar's Tennessee license number on file is MD20951.

NPI and contact details
NPI enumeration date
September 30, 2006
NPI status
Active
Practice phone
(240) 338-1217
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Medical school graduation
1985

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Marshall Summar practices in Chevy Chase and Washington

Dr. Summar's primary practice is Children's Hospital - Chevy Chase, at 5550 Friendship Blvd Ste 580 Suite 580, Chevy Chase, MD 20815. The practice phone is (240) 338-1217. The NPI Registry lists Dr. Summar's practice address as 111 Michigan NW Ave, Washington, DC 20010.

  • Children's Hospital - Chevy ChasePrimary
    5550 Friendship Blvd Ste 580 Suite 580, Chevy Chase, MD 20815Phone(240) 338-1217
  • NPI Registry address
    111 Michigan NW Ave, Washington, DC 20010 · District Of Columbia CountyPhone(202) 379-8295

Sources: NPPES NPI Registry (CMS); Dmand AI Affiliation Data; Doctors and Clinicians National Downloadable File (CMS); and Dmand AI Practice Data

Dr. Marshall Summar is affiliated with 1 site of care and 1 medical group

Dr. Summar's primary practice is Children's Hospital - Chevy Chase in Chevy Chase, Maryland. The medical group on file is Children's National Hospital.

Children's Hospital - Chevy ChasePediatric practice · Chevy Chase, MarylandPrimary
Children's National HospitalPediatrics group, Washington, DC

Sources: Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dmand AI tracks the EHR system at Dr. Marshall Summar's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Summar practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Children's Hospital - Chevy ChaseAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Summar practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Marshall Summar is one of 14 clinical genetics (m.d.) physicians in District of Columbia

Clinical genetics (m.d.) is Dr. Summar's primary specialty in the NPI Registry, under taxonomy code 207SG0201X. Dr. Summar is board certified in clinical biochemical genetics by the American Board of Medical Genetics and Genomics. Dmand AI has Dr. Summar's licenses on file in 4 states: Tennessee, District of Columbia, Virginia and Maryland.

Specialties and state licenses

  • Clinical genetics (m.d.), TennesseePrimaryLicense MD20951 · 1990 to 2011 · taxonomy 207SG0201X
  • District of Columbia license2010 to 2027
  • Virginia license2010 to 2026
  • Maryland license2010 to 2025

Clinical genetics (m.d.) physicians near Dr. Summar

Counts of clinical genetics (m.d.) physicians with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Marshall Summar has 150 publications on record

Dmand AI links 150 papers to Dr. Summar, published from 2004 to 2024. 2015 was the busiest year, with 10. The most frequent topics are Citrulline, Nitric Oxide and Urea. Dr. Summar has published most often in Mol Genet Metab. Dr. Summar's most frequent co-authors are Judy L. Aschner, MD, Frederick E. Barr, MD and Candice Fike, MD.

Papers150
Years published2004 to 2024

Dr. Summar's papers by year, 2014 to 2024

Topics Dr. Summar writes about most

  • Citrulline
  • Nitric Oxide
  • Urea
  • Hyperammonemia
  • Polymorphism, Genetic
  • Amino Acid Metabolism, Inborn Errors
  • Hypertension, Pulmonary
  • Urea Cycle Disorders, Inborn

Dr. Summar's most frequent co-authors

Recent publications by Dr. Summar

See all 150 publications and co-authors

See who Dr. Summar researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Summar works with, so you can find a warm path to the right clinical genetics (m.d.) physicians.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Marshall Summar has worked on 6 clinical trials

Dmand AI links Dr. Summar to 6 clinical trials, 2 of them phase 1 studies. Conditions studied include Anemia, Sickle Cell, Ornithine Carbamoyltransferase Deficiency Disease and Anemia, Hemolytic, Congenital. Nicholas Ah Mew sponsors the most, 2.

Clinical trials with Dr. Summar by phase

  1. 2Phase 1: 2 trials
  2. 2Phase 1/2: 2 trials
  3. 1Phase 2: 1 trial
  4. NonePhase 3: no trials
  5. NonePhase 4: no trials

Conditions in Dr. Summar's trials

  • Anemia, Sickle Cell
  • Ornithine Carbamoyltransferase Deficiency Disease
  • Anemia, Hemolytic, Congenital
  • Urea Cycle Disorders, Inborn
  • Heart Defects, Congenital

Investigators on the most trials with Dr. Summar

Recent clinical trials with Dr. Summar

See all 6 clinical trials and co-investigators

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Marshall Summar received $21,478 in industry payments from 2016 to 2023

CMS Open Payments shows 20 general payments to Dr. Summar from 4 drug and device companies from 2016 to 2023. Travel and lodging make up the largest share, 53% of the total. BioMarin Pharmaceutical Inc. paid the most, $11,563.

General payments to Dr. Summar by program year, 2016 to 2023

General payments to Dr. Summar by kind, 2016 to 2023

$21.5Kin total
  • Travel and lodging$11,45553%
  • Speaker and faculty fees$8,50040%
  • Food and beverage$1,5227%

Companies that paid Dr. Summar the most, 2016 to 2023

Share is of all general payments to this clinician.

See all payments to Dr. Summar

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Marshall Summar has 4 awards and honors on record

Dmand AI lists 4 awards for Dr. Summar, most recently Best Doctors in America™ in 2017. Dr. Summar serves on Global Commission to End the Diagnostic Odyssey for Children with a Rare Disease., Board of Directors National Organization of Rare Diseses and Board National Organization for Rare Disorders.

Awards and honors for Dr. Summar

  1. 2017
    • Best Doctors in America™
  2. 2005
    • Grant Liddle Research Award
  3. 1990
    • Postdoctoral Fellowship, Diabetes Training Grant (NIH Grant T33DK070601)
  4. Undated
    • Super Doc

Dr. Summar's committees and leadership roles

Global Commission to End the Diagnostic Odyssey for Children with a Rare Disease.Comissioner
2018 to present
Board of Directors National Organization of Rare DisesesChairman
2015 to present
Board National Organization for Rare DisordersMember
2012 to present
NIH Genetics Training Programmember
2010 to present
Board of Directors Society of Inherited Metabolic DIsordersPresident-Elect
2006 to present

Source: Dmand AI Professional Profile Data

Dr. Marshall Summar graduated from University of Tennessee Health Science Center College of Medicine - Memphis

Dr. Summar graduated from University of Tennessee Health Science Center College of Medicine - Memphis in 1985. Dr. Summar is a member of AAP, American College of Medical Genetics, American Society of Human Genetics, Society for Inherited Metabolic Diseases and Society for the Study of Inborn Errors of Metabolism.

  1. Medical schoolUniversity of Tennessee Health Science Center College of Medicine - Memphis
  2. Board certified in clinical biochemical geneticsAmerican Board of Medical Genetics and Genomics
  3. Board certified in clinical genetics and genomicsAmerican Board of Medical Genetics and Genomics

Source: Dmand AI Professional Profile Data

Dr. Marshall Summar accepts plans from 10 insurance carriers

Dr. Summar is in network with 10 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.

  • Aetna
  • Elevance
  • United Healthcare
  • CareFirst BlueCross BlueShield
  • Molina
  • Blue Cross Blue Shield of Michigan
  • Aspirus Health Plan
  • Blue Cross and Blue Shield of Kansas City
  • +2 more carriersWith a free account

Plan types Dr. Summar accepts, by number of carriers

  1. PPO6
  2. HMO5
  3. Medicare5
  4. POS5
  5. EPO3
  6. Medicaid2

Source: Dmand AI Insurance Network Data

Sources for Dr. Marshall Summar's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Affiliation DataDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Awards and committee rolesDmand AI Professional Profile Data
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Marshall Summar

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Marshall Summar's NPI number?

Dr. Marshall Summar's NPI number is 1336231745. It was assigned on September 30, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Marshall Summar?

Dr. Marshall Summar is a clinical genetics (m.d.) physician in Washington, District of Columbia. The primary specialty in the NPI Registry is Clinical Genetics (M.D.) Physician (taxonomy code 207SG0201X).

Where does Dr. Marshall Summar practice?

Dr. Summar practices at 5550 Friendship Blvd Ste 580 Suite 580, Chevy Chase, MD 20815. Dr. Summar also practices at 111 Michigan NW Ave, Washington, DC 20010. Dr. Summar's primary practice is Children's Hospital - Chevy Chase in Chevy Chase, Maryland.

What is Dr. Marshall Summar's office phone number?

The practice phone on file for Dr. Summar is (240) 338-1217.

What is Dr. Marshall Summar's medical license number?

Dr. Summar's Tennessee license number on file is MD20951, one of the licenses on file in 4 states.

Which states has Dr. Marshall Summar been licensed in?

Dmand AI has state licenses on file for Dr. Summar in Tennessee (1990 to 2011), District of Columbia (2010 to 2027), Virginia (2010 to 2026) and Maryland (2010 to 2025).

What medical group is Dr. Marshall Summar part of?

Dr. Summar is linked to Children's National Hospital.

Is Dr. Marshall Summar board certified?

Yes. Dr. Summar is board certified in clinical biochemical genetics by the American Board of Medical Genetics and Genomics.

Where did Dr. Marshall Summar go to medical school?

Dr. Summar graduated from University of Tennessee Health Science Center College of Medicine - Memphis in 1985.

Has Dr. Marshall Summar received payments from drug or device companies?

CMS Open Payments shows $21,478 in general payments to Dr. Summar from 4 companies from 2016 to 2023. The largest total came from BioMarin Pharmaceutical Inc.

Show 4 more questionsShow fewer questions

How long has Dr. Marshall Summar been practicing?

Dr. Summar graduated from medical school in 1985, 41 years ago.

Does Dr. Marshall Summar do research?

Dmand AI links 150 publications to Dr. Summar, published from 2004 to 2024. Dr. Summar has worked on 6 clinical trials.

Who does Dr. Marshall Summar publish with?

Dr. Summar's most frequent co-authors are Judy L. Aschner, MD (12 shared papers), Frederick E. Barr, MD (10 shared papers) and Candice Fike, MD (7 shared papers).

What insurance does Dr. Marshall Summar accept?

Dr. Summar is in network with 10 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.

Selling to clinical genetics (m.d.) practices?

See clinical genetics (m.d.) physicians in District of Columbia by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)